GO:0030957 Tat protein binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030957 Tat protein binding describes the molecular function of binding to Tat, the viral transactivating regulatory protein of human immunodeficiency virus (HIV).
• Tat binds the transactivation response (TAR) RNA stem-loop, specifically a U-rich bulge, to stimulate viral transcription.
• Tat also binds host proteins and chromatin, with genome-wide mapping showing thousands of binding sites across the human genome.
• Tat-controlled acetylation regulates its activity and interaction with cofactors such as PCAF and p300/CBP.
• Tat interacts with transcription factors such as Sp3 and modulates host gene promoters, including sod2, in endothelial cells.
• Studying Tat protein binding informs HIV latency, neuroAIDS, Tat-targeted therapeutics, and CRISPR-based host-factor screens [5,3].
Description
Tat protein binding (GO:0030957) is a molecular function defined as binding to Tat, a viral transactivating regulatory protein from the human immunodeficiency virus, or the equivalent protein from another virus. Tat is essential for efficient HIV-1 transcription: it binds the TAR RNA element and recruits host positive transcription elongation factor b (P-TEFb) to overcome promoter-proximal pausing [5,8]. Because Tat has no known cellular homolog, its binding interactions are attractive targets for antiviral intervention. Beyond TAR RNA, Tat binds numerous host proteins and genomic loci, thereby reprogramming cellular gene expression [3,2]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to explain the mechanism, key genes, disease links, and research methods for Tat protein binding.
Tat protein binding At A Glance
| GO ID | GO:0030957 |
|---|---|
| GO term | Tat protein binding |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Binding to HIV Tat protein or equivalent viral transactivator |
| Definition source | QuickGO |
| Related viral protein | HIV-1 Tat |
| Key binding partner | TAR RNA U-rich bulge |
| Representative host interactors | Sp3, PCAF, p300/CBP [2,1] |
What Is GO:0030957?
In the Gene Ontology, GO:0030957 (Tat protein binding) is a molecular function term: binding to Tat, a viral transactivating regulatory protein from the human immunodeficiency virus, or the equivalent protein from another virus. It encompasses direct physical interactions between a binding partner (protein, RNA, or other molecule) and Tat, as supported by experimental evidence such as RNA-binding assays, protein interaction studies, and genome-wide binding maps [8,3].
Why Is Tat protein binding Important in Cell Biology?
Tat protein binding is central to HIV-1 pathogenesis because Tat is required for robust viral transcription and because Tat-host interactions contribute to viral latency, immune evasion, and HIV-associated comorbidities [5,3]. Understanding these interactions provides mechanistic insight into transcriptional control and identifies candidate targets for host-directed therapies [5,2].
• Tat binding to TAR RNA is essential for HIV-1 transcriptional elongation.
• Tat recruits host coactivators such as PCAF and p300/CBP, linking viral transcription to chromatin acetylation.
• Genome-wide Tat binding maps reveal widespread host genome occupancy, suggesting broad gene regulation.
• Tat interaction with Sp3 inhibits Sp3 binding to the sod2 promoter, affecting oxidative stress responses.
• Tat protein transduction domain binds heparin, relevant to Tat uptake and extracellular functions.
• Tat activates transcription from upstream DNA-binding sites, expanding its regulatory repertoire.
• Tat binding to CD26 is not observed, highlighting specificity of Tat interactions.
• Tat is a validated target for anti-HIV therapeutics and latency-reversing strategies.
Molecular Mechanism of Tat protein binding
Tat-TAR RNA recognition
In simple terms: Tat grabs a specific bulge in the viral RNA to start transcription.
Tat binds a U-rich bulge in the stem of the TAR RNA structure, an interaction that is required for Tat to stimulate transcription. This RNA-protein contact is the founding example of Tat protein binding and remains the best-characterized binding event for GO:0030957.
Tat acetylation and cofactor recruitment
In simple terms: Tat gets chemically tagged, which changes who it binds and how strongly it activates transcription.
Tat-controlled protein acetylation regulates Tat activity; acetylation of Tat modulates its interaction with transcriptional coactivators such as PCAF and p300/CBP. These post-translational modifications influence the stability and composition of Tat-containing complexes.
Genome-wide Tat binding to host chromatin
In simple terms: Tat does not only bind viral RNA; it also lands on many places in human DNA.
A genome-wide binding map of HIV-1 Tat in human cells identified thousands of Tat binding sites across the host genome, indicating that Tat protein binding extends beyond TAR RNA to chromatin-associated targets. This broad occupancy suggests Tat can influence host gene expression programs.
Tat interaction with host transcription factors
In simple terms: Tat can tie up host transcription factors and change which genes they control.
The HIV-Tat protein interacts with the Sp3 transcription factor and inhibits its binding to a distal site of the sod2 promoter in human pulmonary artery endothelial cells. This demonstrates that Tat protein binding can sequester or displace host factors, altering host gene regulation.
Tat protein transduction domain and heparin binding
In simple terms: Part of Tat can stick to heparin-like molecules, which helps Tat enter cells and act outside the virus.
The HIV-1 Tat protein transduction domain binds heparin, an interaction relevant to Tat internalization and extracellular activities. This binding property is distinct from TAR RNA recognition but falls under the broad functional umbrella of Tat protein binding.
Specificity of Tat binding
In simple terms: Tat does not bind everything; some proposed partners do not actually interact.
Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26 was reported, indicating that Tat binding is selective and that negative results help define the true interactome. Such specificity is important when annotating GO:0030957.
Key Genes Involved in GO:0030957 Tat protein binding
The following genes and proteins are directly implicated in Tat protein binding or its functional consequences according to the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Tat (HIV-1) | Viral transactivator; binds TAR RNA and host factors | Core ligand for GO:0030957; target for antiviral strategies [5,8] |
| TAR (HIV-1 RNA element) | RNA stem-loop bound by Tat | Defines the canonical Tat-RNA interaction |
| CDK9 | Catalytic subunit of P-TEFb recruited by Tat | Tat binding to TAR leads to P-TEFb recruitment for elongation |
| Cyclin T1 (CCNT1) | Regulatory subunit of P-TEFb | Part of the Tat-P-TEFb complex |
| PCAF (KAT2B) | Histone acetyltransferase that acetylates Tat | Tat acetylation modulates cofactor binding |
| p300/CBP (EP300/CREBBP) | Transcriptional coactivators and acetyltransferases | Acetylate Tat and support Tat-dependent transcription |
| Sp3 | Host transcription factor interacting with Tat | Tat binding inhibits Sp3 binding to sod2 promoter |
| sod2 | Mitochondrial antioxidant enzyme gene | Promoter regulation affected by Tat-Sp3 interaction |
| CD26 (DPP4) | Cell surface protease | Tat does not bind CD26, defining specificity |
| Adenosine deaminase (ADA) | Enzyme that binds CD26 | Control for Tat binding specificity |
| Heparin (glycosaminoglycan) | Binds Tat protein transduction domain | Relevant to Tat uptake and extracellular function |
| TAR RNA | RNA target of Tat | Model for RNA-protein binding studies |
| P-TEFb complex | Elongation factor recruited by Tat | Central to Tat transactivation mechanism |
| NF-kB pathway components | Tat activates transcription from upstream DNA-binding sites | Implicates Tat in inflammatory gene regulation |
| Chromatin-associated factors | Genome-wide Tat binding partners | Potential mediators of Tat host gene regulation |
| HIV-1 LTR promoter | Viral promoter containing TAR | Site of Tat-dependent transcription activation [6,8] |
| Tat-interacting proteins (various) | Host proteins bound by Tat | Candidate targets for host-directed therapy |
How Is Tat protein binding Regulated?
Tat protein binding is regulated by post-translational acetylation of Tat, which controls its interaction with coactivators such as PCAF and p300/CBP. The availability of TAR RNA and the recruitment of P-TEFb further determine the functional outcome of Tat binding [5,8]. Host factors such as Sp3 can compete with or be displaced by Tat at specific promoters, adding another layer of regulation.
Tat protein binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Tat (HIV-1) | HIV-1 infection/AIDS | Tat-expressing cell lines; HIV-1 latency models |
| TAR RNA | HIV-1 transcription | TAR reporter assays; RNA-binding assays |
| Sp3 | Endothelial dysfunction; oxidative stress | Sp3 knockout endothelial cells; sod2 promoter assays |
| PCAF (KAT2B) | HIV transcription regulation | PCAF knockout or point-mutant cells; acetylation assays |
| p300/CBP | HIV transcription regulation | EP300/CREBBP knockout cells; co-IP assays |
HIV-1 infection and AIDS
Tat protein binding is essential for HIV-1 transcription and viral replication; Tat binds TAR RNA and recruits P-TEFb to stimulate elongation [5,8]. Disrupting Tat-TAR or Tat-cofactor interactions is a therapeutic strategy for HIV-1.
HIV-associated neurocognitive disorders and endothelial dysfunction
Tat interacts with Sp3 and inhibits its binding to the sod2 promoter in human pulmonary artery endothelial cells, linking Tat protein binding to oxidative stress and endothelial biology relevant to HIV comorbidities.
Tat as a broad regulator of host gene expression
Genome-wide mapping shows Tat binds many sites in the human genome, suggesting that Tat protein binding can perturb host gene programs and contribute to HIV-associated pathologies beyond viral replication.
Tat acetylation and transcriptional dysregulation
Tat-controlled acetylation affects its binding to coactivators, which may influence the magnitude and duration of viral and host gene transcription.
From Tat protein binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a host gene regulate Tat binding to TAR? | Knockout cell line (e.g., CRISPR KO of candidate gene) |
| Does a point mutation in Tat abolish TAR binding? | Point-mutation knock-in of Tat mutant |
| Can a tagged Tat be used to map binding sites? | Tagged knock-in of Tat (e.g., FLAG or HA) |
| Does overexpression of a cofactor enhance Tat transactivation? | Overexpression cell model |
| Which host factors are required for Tat binding? | CRISPR library screening |
| Does Tat binding alter host gene expression? | RNA-seq after Tat expression |
How to Study the Tat protein binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EMSA | Tat-TAR RNA binding affinity | Characterize Tat mutants |
| ChIP-seq | Genome-wide Tat binding sites | Map host genome occupancy |
| Co-IP | Tat-protein interactions | Validate Sp3, PCAF binding [2,1] |
| Acetylation assay | Tat acetylation status | Study PCAF/p300 effects |
| Heparin binding assay | Tat-heparin interaction | Analyze Tat uptake |
| Luciferase reporter | Tat transactivation activity | Screen inhibitors |
| CRISPR knockout | Host gene requirement for Tat binding | Functional screens |
| RNA-seq | Host gene expression changes | Tat expression effects |
RNA-protein binding assays
Electrophoretic mobility shift assays (EMSA) and UV crosslinking can measure Tat binding to TAR RNA, as demonstrated for the U-rich bulge interaction.
Genome-wide binding mapping
ChIP-seq or related methods can map Tat binding across the human genome, revealing thousands of sites and potential host targets.
Protein interaction studies
Co-immunoprecipitation, pull-down, and yeast two-hybrid assays can identify and validate Tat-host protein interactions, such as Tat-Sp3 and Tat-PCAF [2,1].
Acetylation and post-translational modification assays
In vitro and in vivo acetylation assays using radioactive acetyl-CoA or acetyl-lysine antibodies can detect Tat acetylation and its effect on binding.
Heparin binding assays
Heparin-Sepharose chromatography or surface plasmon resonance can measure Tat protein transduction domain binding to heparin.
Transcriptional reporter assays
HIV-1 LTR reporter assays with or without TAR can quantify Tat-dependent transcription activation [6,8].
How CRISPR Can Be Used to Study GO:0030957 Tat protein binding
Knockout
CRISPR knockout of host genes such as Sp3, PCAF, or EP300 can test whether they are required for Tat protein binding or Tat-mediated transcription [2,1].
Point Mutation
Point mutations in Tat or TAR can be introduced to dissect the precise residues or bases required for binding, as informed by the U-rich bulge interaction.
Knock-in
Knock-in of tagged Tat (e.g., FLAG, HA) allows affinity purification and genome-wide mapping of Tat binding sites.
Overexpression
Overexpression of Tat or its cofactors can enhance Tat binding and transactivation, enabling gain-of-function studies.
How EDITGENE Supports Tat protein binding Research
Researchers studying Tat protein binding-related genes often need to determine whether a candidate gene is causally involved in Tat interaction, Tat-dependent transcription, or downstream host responses. EDITGENE provides CRISPR-based cell model services to enable such functional validation.
Contact EDITGENE today to design your custom CRISPR model for Tat protein binding research.
Frequently Asked Questions About Tat protein binding
What is GO:0030957 Tat protein binding?
GO:0030957 is a Gene Ontology molecular function term describing binding to Tat, a viral transactivating regulatory protein from HIV or an equivalent viral protein.
What genes are involved in Tat protein binding?
Key genes include HIV-1 Tat, TAR RNA, CDK9, Cyclin T1, PCAF, p300/CBP, and Sp3, among others [5,8,1,2].
How does Tat bind TAR RNA?
Tat binds a U-rich bulge in the stem of the TAR RNA structure to stimulate transcription.
Does Tat bind host proteins?
Yes, Tat interacts with host factors such as Sp3 and acetyltransferases PCAF and p300/CBP [2,1].
Where does Tat bind in the human genome?
Genome-wide mapping has identified thousands of Tat binding sites across the human genome.
Is Tat binding to CD26 specific?
No, specific binding of adenosine deaminase but not Tat to human CD26 has been reported, indicating selectivity.
How is Tat protein binding regulated?
Tat acetylation by PCAF and p300/CBP regulates its interactions and activity.
What diseases are linked to Tat protein binding?
HIV-1 infection/AIDS and HIV-associated endothelial dysfunction are linked to Tat protein binding [5,2].
What methods study Tat protein binding?
EMSA, ChIP-seq, co-IP, acetylation assays, and reporter assays are commonly used [8,3,2,1,6].
Can CRISPR be used to study Tat protein binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect Tat-host interactions [5,3].
Conclusion
Tat protein binding (GO:0030957) is a molecular function with central importance for HIV-1 biology and host-pathogen interactions. The canonical Tat-TAR RNA interaction, Tat acetylation, and genome-wide host binding collectively define a complex regulatory network [8,1,3]. Understanding these interactions offers opportunities for therapeutic intervention and for fundamental studies of transcriptional control [5,2].
References
- 1. Col E et al.. 2002. Tat-controlled protein acetylation.. J Biol Chem 277(40):37955-60 PMID: 12154097
- 2. Manes TL et al.. 2020. The HIV-Tat protein interacts with Sp3 transcription factor and inhibits its binding to a distal site of the sod2 promoter in human pulmonary artery endothelial cells.. Free Radic Biol Med 147:102-113 PMID: 31863909
- 3. Marban C et al.. 2011. Genome-wide binding map of the HIV-1 Tat protein to the human genome.. PLoS One 6(11):e26894 PMID: 22073215
- 4. Hakansson S et al.. 2001. Heparin binding by the HIV-1 tat protein transduction domain.. Protein Sci 10(10):2138-9 PMID: 11567105
- 5. Karn J. 1999. Tackling Tat.. J Mol Biol 293(2):235-54 PMID: 10550206
- 6. Southgate CD et al.. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function.. Genes Dev 5(12B):2496-507 PMID: 1752440
- 7. Blanco J et al.. 1996. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.. Exp Cell Res 225(1):102-11 PMID: 8635502
- 8. Dingwall C et al.. 1990. HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure.. EMBO J 9(12):4145-53 PMID: 2249668
